Quintiles, the world’s largest biopharmaceutical services company, has been named to FORTUNE magazine’s “World’s Most Admired Companies” list...
22.2% growth in net new business compared to the fourth quarter of 2013 representing a book-to-bill ratio of 1.49 9.3% constant...
Quintiles, the world’s largest biopharmaceutical services company, is working with the National Football League (NFL) to track player injuries...
Quintiles Transnational Holdings Inc. (“Quintiles” or the “Company”) (NYSE: Q) announced today that Dr. John Leonard, MD, has been appointed...
アジアの一流学術研究者とクインタイルズの専門家が共同で作成 (ビジネスワイヤ) -- クインタイルズは本日、研究者主導型臨床試験を実施する際に医師...
Joint Effort by Leading Asian Academic Researchers and Quintiles’ Experts Quintiles today announced the launch of a handbook to guide...
助成金で大腸がんと卵巣がんの研究を支援 (ビジネスワイヤ) -- クインタイルズ子会社のエクスプレッション・アナリシス(EA)は本日、ゲノム研究を前...
Quintiles Transnational Holdings Inc. (NYSE:Q) will release its fourth-quarter 2014 financial results Thursday, February 12, 2015 prior to...
Mit Förderung wird Forschung zu Kolorektal- und Ovarialkarzinomen unterstützt Expression Analysis (EA), ein Tochterunternehmen von...
Les subventions permettront de soutenir la recherche sur le cancer colorectal et ovarien Expression Analysis (EA), une société Quintiles, a...
Awards will Support Colorectal and Ovarian Cancer Research Expression Analysis (EA), a Quintiles company, today announced the winners of a...
January 14, 2015 Quintiles CEO Tom Pike will present at the 2015 J.P. Morgan Healthcare Conference on Wednesday, January 14, 2015 in San...
8年間で6度目となる受賞は、当地域におけるクインタイルズの市場リーダーシップを浮き彫りに (ビジネスワイヤ) -- クインタイルズは事業調査・コンサ...
(ビジネスワイヤ) -- クインタイルズは本日、毎年恒例のスクリップ賞の「最優秀CRO(医薬品開発業務受託機関)賞」を3年連続で獲得したと発表しました。...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.